Clinuvel Pharmaceuticals (ASX: CUV) Share Price

CUV

$8.96▲+1.24%

$451.7MRank #478 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$451.7M

Volume

94K

P/E Ratio

14.96

EPS

$0.2082

Dividend Yield

0.40%

52-Week High

$14.00

52-Week Low

$8.35

Beta

0.606

Clinuvel Pharmaceuticals (ASX: CUV) is an Australian-listed company in the Healthcare sector with a market capitalisation of $451.7M and the 478th-largest security on the ASX by market capitalisation. The CUV share price is $8.96, up 1.24% today and down 11.79% over the past 12 months. Shares have traded between $8.35 and $14.00 over the past 52 weeks. CUV trades on a price-to-earnings ratio of 14.96, above the Healthcare sector median of 14.96, and pays a trailing dividend yield of 0.40%. In its most recent reported period (ending 31 Dec 2025), Clinuvel Pharmaceuticals reported revenue of $36.9M and a net profit of $10.4M (28.3% margin).

Charts

$8.98

24H Range

$8.80

$9.00

52-Week Range

$8.35

$14.00

About Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of treatments for patients battling genetic, metabolic, and life-threatening conditions. Its reach extends across Australia, Europe, the United States, Switzerland, and other global markets. The company's flagship drug, SCENESSE, serves as a systemic photoprotective treatment intended to prevent phototoxicity in adult patients diagnosed with erythropoietic protoporphyria (EPP). Clinuvel's development pipeline includes CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which promotes prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Additionally, Clinuvel Pharmaceuticals has partnered with HK Winhealth Pharma Group Co. Limited for a named patient program in the People's Republic of China, enabling the treatment of EPP patients with SCENESSE. Founded in 1987, the company's corporate headquarters are situated in Melbourne, Australia.

IPO Date

11 Feb 2001

CEO

Philippe Jacques Wolgen

Employees

Website

clinuvel.com

Key Financial Data

Revenue (Quarterly)	$36.9M
Net Income (Quarterly)	$10.4M
Total Assets	$269.7M
Total Debt	$341,091
Free Cash Flow	$12.4M
Return on Equity	4.19%
Profit Margin	28.28%
Operating Margin	29.67%

CUV Frequently Asked Questions

What is the Clinuvel Pharmaceuticals (ASX: CUV) share price?

The CUV share price is $8.96, up 1.24% for the day, based on the latest available ASX market data.

What is Clinuvel Pharmaceuticals's market capitalisation?

Clinuvel Pharmaceuticals has a market capitalisation of $451.7M, making it the 478th-largest security listed on the ASX.

Does Clinuvel Pharmaceuticals pay a dividend?

Yes. CUV has a trailing dividend yield of 0.40%.

What is CUV's P/E ratio?

Clinuvel Pharmaceuticals trades on a trailing price-to-earnings (P/E) ratio of 14.96, based on its current share price and most recent reported earnings.

Is Clinuvel Pharmaceuticals profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), CUV reported revenue of $36.9M and a net profit of $10.4M.

How many CUV shares are on issue?

Clinuvel Pharmaceuticals has approximately 50,410,800 shares on issue, based on its market capitalisation of $451.7M and current share price.

What sector is Clinuvel Pharmaceuticals in?

Clinuvel Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Clinuvel Pharmaceuticals list on the ASX?

Clinuvel Pharmaceuticals listed on the Australian Securities Exchange on 11 Feb 2001.

Latest News

One Healthcare Stock to Gain from Long-term Expansion Strategy - Clinuvel Pharmaceuticals Limited

Kalkine12 June 2026

One Healthcare Stock to Gain from Long-term Expansion Strategy - Clinuvel Pharmaceuticals Limited Kalkine

Insights: Clinuvel Pharmaceuticals Ltd (ASX:CUV)

smallcaps.com.au30 Oct 2025

Insights: Clinuvel Pharmaceuticals Ltd (ASX:CUV) smallcaps.com.au

A Look At Clinuvel Pharmaceuticals (ASX:CUV) Valuation After Softer Half Year Earnings Results

simplywall.st9 Mar 2026

A Look At Clinuvel Pharmaceuticals (ASX:CUV) Valuation After Softer Half Year Earnings Results simplywall.st

Health Check: Cash is king in these troubled times, declares defiant Clinuvel

Stockhead4 Mar 2026

Health Check: Cash is king in these troubled times, declares defiant Clinuvel Stockhead

This ASX 300 stock is racing 6% higher on exciting news

The Motley Fool Australia12 Jan 2026

This ASX 300 stock is racing 6% higher on exciting news The Motley Fool Australia

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
RACRace Oncology Limited	$468.1M	$2.40	-29.29	0.00%	▲+1.69%
CGSCogstate Limited	$465.5M	$2.74	20.94	0.59%	▼-0.36%
OCAOceania Healthcare Limited	$420.1M	$0.58	-26.28	0.00%	▲+0.87%
ACLAustralian Clinical Labs Limited	$405.4M	$2.16	23.92	3.29%	–+0.00%
HLSHealius Limited	$261.4M	$0.36	-5.40	0.00%	▲+5.88%
PGCParagon Care Limited	$248.3M	$0.15	-4.18	0.00%	▼-3.23%
EBREBR Systems, Inc.	$169.0M	$0.375	-28.93	0.00%	–+0.00%

ETFs That Hold CUV

CUV is held by 2 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.16% of its portfolio.

Fund	Portfolio Weight	Fund Size
ISOiShares S&P/ASX Small Ordinaries ETF	0.16%	$134.5M
VASVanguard Australian Shares Index ETF	0.02%	$26.10B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$8.85	$9.00	$8.80	$8.98	90K	▲+1.35%
11 June 2026	$8.60	$8.88	$8.35	$8.86	184K	▲+1.55%
10 June 2026	$8.91	$8.94	$8.69	$8.725	100K	▼-1.97%
9 June 2026	$9.04	$9.05	$8.86	$8.90	59K	▼-2.52%
8 June 2026	$8.86	$9.18	$8.86	$9.13	49K	▲+0.55%
5 June 2026	$8.86	$9.18	$8.86	$9.08	47K	▲+1.45%
4 June 2026	$8.80	$9.08	$8.80	$8.95	53K	▲+1.36%
3 June 2026	$8.95	$8.95	$8.70	$8.83	136K	▼-2.00%
2 June 2026	$9.15	$9.20	$8.95	$9.01	47K	▼-2.70%
1 June 2026	$9.04	$9.29	$9.04	$9.26	66K	▲+1.98%
29 May 2026	$8.96	$9.12	$8.845	$9.08	65K	▲+1.68%
28 May 2026	$8.82	$9.00	$8.72	$8.93	61K	▲+0.79%
27 May 2026	$8.95	$8.96	$8.81	$8.86	24K	▼-0.45%
26 May 2026	$8.98	$9.00	$8.80	$8.90	41K	▲+0.68%
25 May 2026	$9.08	$9.08	$8.80	$8.84	139K	▼-2.64%
22 May 2026	$9.21	$9.28	$9.08	$9.08	111K	▼-1.41%
21 May 2026	$8.99	$9.30	$8.99	$9.21	84K	▲+3.14%
20 May 2026	$9.17	$9.27	$8.93	$8.93	75K	▼-2.72%
19 May 2026	$9.06	$9.34	$9.06	$9.18	45K	▲+0.22%
18 May 2026	$9.48	$9.55	$9.05	$9.16	65K	▼-3.32%
15 May 2026	$9.43	$9.60	$9.41	$9.475	46K	▼-0.16%
14 May 2026	$9.22	$9.52	$9.22	$9.49	28K	▲+1.17%
13 May 2026	$9.35	$9.50	$9.27	$9.38	47K	▲+0.32%
12 May 2026	$9.48	$9.59	$9.30	$9.35	64K	▼-2.25%
11 May 2026	$9.32	$9.60	$9.06	$9.565	84K	▲+1.43%
8 May 2026	$9.56	$9.60	$9.40	$9.43	36K	▼-1.05%
7 May 2026	$9.48	$9.64	$9.35	$9.53	73K	▲+2.25%
6 May 2026	$9.60	$9.60	$9.30	$9.32	81K	▼-2.36%
5 May 2026	$9.33	$9.66	$9.31	$9.545	127K	▲+3.08%
4 May 2026	$9.30	$9.33	$9.10	$9.26	36K	▲+1.09%

About Clinuvel Pharmaceuticals Limited

IPO Date

11 Feb 2001

CEO

Philippe Jacques Wolgen

Employees

Website

clinuvel.com

CUV Frequently Asked Questions

What is the Clinuvel Pharmaceuticals (ASX: CUV) share price?

The CUV share price is $8.96, up 1.24% for the day, based on the latest available ASX market data.

What is Clinuvel Pharmaceuticals's market capitalisation?

Clinuvel Pharmaceuticals has a market capitalisation of $451.7M, making it the 478th-largest security listed on the ASX.

Does Clinuvel Pharmaceuticals pay a dividend?

Yes. CUV has a trailing dividend yield of 0.40%.

What is CUV's P/E ratio?

Clinuvel Pharmaceuticals trades on a trailing price-to-earnings (P/E) ratio of 14.96, based on its current share price and most recent reported earnings.

Is Clinuvel Pharmaceuticals profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), CUV reported revenue of $36.9M and a net profit of $10.4M.

How many CUV shares are on issue?

Clinuvel Pharmaceuticals has approximately 50,410,800 shares on issue, based on its market capitalisation of $451.7M and current share price.

What sector is Clinuvel Pharmaceuticals in?

Clinuvel Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Clinuvel Pharmaceuticals list on the ASX?

Clinuvel Pharmaceuticals listed on the Australian Securities Exchange on 11 Feb 2001.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
RACRace Oncology Limited	$468.1M	$2.40	-29.29	0.00%	▲+1.69%
CGSCogstate Limited	$465.5M	$2.74	20.94	0.59%	▼-0.36%
OCAOceania Healthcare Limited	$420.1M	$0.58	-26.28	0.00%	▲+0.87%
ACLAustralian Clinical Labs Limited	$405.4M	$2.16	23.92	3.29%	–+0.00%
HLSHealius Limited	$261.4M	$0.36	-5.40	0.00%	▲+5.88%
PGCParagon Care Limited	$248.3M	$0.15	-4.18	0.00%	▼-3.23%
EBREBR Systems, Inc.	$169.0M	$0.375	-28.93	0.00%	–+0.00%

Fund

Portfolio Weight

Fund Size

ISOiShares S&P/ASX Small Ordinaries ETF

0.16%

$134.5M

VASVanguard Australian Shares Index ETF

0.02%

$26.10B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$8.85	$9.00	$8.80	$8.98	90K	▲+1.35%
11 June 2026	$8.60	$8.88	$8.35	$8.86	184K	▲+1.55%
10 June 2026	$8.91	$8.94	$8.69	$8.725	100K	▼-1.97%
9 June 2026	$9.04	$9.05	$8.86	$8.90	59K	▼-2.52%
8 June 2026	$8.86	$9.18	$8.86	$9.13	49K	▲+0.55%
5 June 2026	$8.86	$9.18	$8.86	$9.08	47K	▲+1.45%
4 June 2026	$8.80	$9.08	$8.80	$8.95	53K	▲+1.36%
3 June 2026	$8.95	$8.95	$8.70	$8.83	136K	▼-2.00%
2 June 2026	$9.15	$9.20	$8.95	$9.01	47K	▼-2.70%
1 June 2026	$9.04	$9.29	$9.04	$9.26	66K	▲+1.98%
29 May 2026	$8.96	$9.12	$8.845	$9.08	65K	▲+1.68%
28 May 2026	$8.82	$9.00	$8.72	$8.93	61K	▲+0.79%
27 May 2026	$8.95	$8.96	$8.81	$8.86	24K	▼-0.45%
26 May 2026	$8.98	$9.00	$8.80	$8.90	41K	▲+0.68%
25 May 2026	$9.08	$9.08	$8.80	$8.84	139K	▼-2.64%
22 May 2026	$9.21	$9.28	$9.08	$9.08	111K	▼-1.41%
21 May 2026	$8.99	$9.30	$8.99	$9.21	84K	▲+3.14%
20 May 2026	$9.17	$9.27	$8.93	$8.93	75K	▼-2.72%
19 May 2026	$9.06	$9.34	$9.06	$9.18	45K	▲+0.22%
18 May 2026	$9.48	$9.55	$9.05	$9.16	65K	▼-3.32%
15 May 2026	$9.43	$9.60	$9.41	$9.475	46K	▼-0.16%
14 May 2026	$9.22	$9.52	$9.22	$9.49	28K	▲+1.17%
13 May 2026	$9.35	$9.50	$9.27	$9.38	47K	▲+0.32%
12 May 2026	$9.48	$9.59	$9.30	$9.35	64K	▼-2.25%
11 May 2026	$9.32	$9.60	$9.06	$9.565	84K	▲+1.43%
8 May 2026	$9.56	$9.60	$9.40	$9.43	36K	▼-1.05%
7 May 2026	$9.48	$9.64	$9.35	$9.53	73K	▲+2.25%
6 May 2026	$9.60	$9.60	$9.30	$9.32	81K	▼-2.36%
5 May 2026	$9.33	$9.66	$9.31	$9.545	127K	▲+3.08%
4 May 2026	$9.30	$9.33	$9.10	$9.26	36K	▲+1.09%